Cigna Group $CI Stock Position Cut by Maj Invest Holding A S

Maj Invest Holding A S decreased its position in Cigna Group (NYSE:CI) by 1.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 439,652 shares of the health services provider’s stock after selling 4,341 shares during the quarter. Cigna Group accounts for approximately 5.3% of Maj Invest Holding A S’s holdings, making the stock its 6th largest holding. Maj Invest Holding A S’s holdings in Cigna Group were worth $119,512,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after buying an additional 840,098 shares during the last quarter. GQG Partners LLC bought a new position in shares of Cigna Group in the 2nd quarter valued at about $1,628,918,000. Bank of America Corp DE increased its position in shares of Cigna Group by 8.8% in the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock valued at $848,821,000 after acquiring an additional 256,677 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Cigna Group by 10.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after acquiring an additional 236,340 shares during the last quarter. Finally, Legal & General Group Plc bought a new stake in Cigna Group during the second quarter worth about $542,779,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Trading Down 1.2%

Shares of NYSE:CI opened at $294.76 on Thursday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $316.27. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The company has a market capitalization of $77.89 billion, a P/E ratio of 12.20, a price-to-earnings-growth ratio of 1.04 and a beta of 0.29. The company has a 50-day simple moving average of $282.97 and a 200 day simple moving average of $281.33.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The firm had revenue of $71.56 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the business earned $7.20 earnings per share. The business’s revenue was up 6.7% compared to the same quarter last year. Sell-side analysts forecast that Cigna Group will post 30.49 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s dividend payout ratio is 25.82%.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna declared a quarterly cash dividend of $1.56 per share, payable December 17 to shareholders of record on December 3. The payment reinforces shareholder returns and signals continued financial stability, although the unchanged dividend may already be reflected in the stock. The Cigna Group Declares Quarterly Dividend
• Positive Sentiment: Piper Sandler reiterated a $370 price target, suggesting substantial potential upside from recent trading levels and continued analyst confidence in Cigna’s valuation. Piper Sandler Reiterates $370 Target
• Neutral Sentiment: Cigna scheduled its next quarterly results for November 5. The report is likely to be the next significant catalyst, particularly for guidance, medical-cost trends, client retention and profitability. Cigna Sets November 5 Results Date
• Neutral Sentiment: Recent analysis argues that retaining clients is less important than ensuring contracts are profitable. This keeps investor focus on the quality of Cigna’s earnings and margins rather than enrollment growth alone. Client Retention Matters, But Contract Profitability Matters More
• Negative Sentiment: A newly introduced House bill would impose stricter prior-authorization deadlines, greater benefit transparency, limits on midyear coverage changes, reimbursement requirements and penalties for billing errors. Cigna could face higher administrative and compliance costs if the proposal advances, though it currently has no cosponsors and most healthcare provisions would not take effect until 2029. Ending Patient Runaround Act

Insiders Place Their Bets

In other Cigna Group news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of Cigna Group stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. The trade was a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 22,730 shares of company stock worth $6,293,359. 0.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CI. Jefferies Financial Group cut Cigna Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. UBS Group restated a “buy” rating on shares of Cigna Group in a research note on Thursday, October 1st. Guggenheim boosted their price target on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Sanford C. Bernstein reiterated an “outperform” rating on shares of Cigna Group in a research note on Friday, October 2nd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Fifteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $338.24.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.